FdaApplication

ANDA 211897

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2022-08-18

Products (3)

ProductActive ingredientStrengthDosage form
APREMILASTAPREMILAST10MGTABLET;ORAL
APREMILASTAPREMILAST20MGTABLET;ORAL
APREMILASTAPREMILAST30MGTABLET;ORAL

3 products